Oruka Therapeutics (ORKA) Depreciation & Amortization (CF) (2010 - 2026)
Oruka Therapeutics (ORKA) recorded quarterly Depreciation & Amortization (CF) of $43000.0 in Q1 2026, up 53.57% quarter-over-quarter from $28000.0 in Q4 2025, and up 168.75% on a YoY basis from $16000.0 in Q1 2025.
Oruka Therapeutics (ORKA) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Oruka Therapeutics' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $43000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 168.75% year-over-year to $43000.0; the TTM figure through Mar 2026 stood at $110000.0 (up 214.29% YoY), while the FY2025 annual figure was $83000.0, up 207.41% from the prior year.
- Depreciation & Amortization (CF) was $43000.0 for Q1 2026 at Oruka Therapeutics, up from $28000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $43000.0 in Q1 2026 to a low of $3000.0 in Q4 2023.
- Historically, Depreciation & Amortization (CF) has averaged $11437.5 across 5 years, with a median of $5000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) plunged 40.0% in 2023, then jumped 533.33% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $5000.0 in 2022, then slumped by 40.0% to $3000.0 in 2023, then jumped by 433.33% to $16000.0 in 2024, then surged by 75.0% to $28000.0 in 2025, then jumped by 53.57% to $43000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $43000.0 (Q1 2026), $28000.0 (Q4 2025), and $20000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 429,663.65 |
| 10 | Oruka Therapeutics | 3.86 Bn | 3.47 Bn | - | 43,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,000.00 |
| Mar 31, 2026 | 43,000.00 |
| Dec 31, 2025 | 28,000.00 |
| Dec 31, 2025 | 28,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Sep 30, 2023 | 4,000.00 |